Accelovance Purchases nTouch Research Assets

Accelovance has completed the asset purchase of nTouch Research, a Raleigh, N.C.-based site management organization (SMO). Financial details were not disclosed. nTouch's clinical capabilities are a key component in Accelovance's strategy to provide trial management services that result in meeting trial timelines in a high quality and cost-effective manner. By combining high-level targeted patient recruitment with quality-focused, integrated, and centralized managed sites, Accelovance improves productivity and quality when conducting multicenter Phase II through IV studies.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18904520&full=1)